BioLineRx Ltd. to Present at the Oppenheimer 14th Annual Israeli Conference on May 12th
5/9/2013 7:44:34 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, announced today that its Chief Executive Officer, Kinneret Savitsky, Ph.D., and its Chief Financial and Operating Officer, Philip Serlin, will present at the Oppenheimer 14th Annual Israeli Conference on Sunday, May 12, 2013, at 12:00 p.m. Israeli local time. The conference is being held at the David Intercontinental Hotel in Tel Aviv, Israel.
Help employers find you! Check out all the jobs and post your resume.
comments powered by